Immuneering Corporation Company Profile
Immuneering Corporation as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, Massachusetts, 02142, United States.
- Mailing address: Value 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, Massachusetts, 02142, United States.
| Measure | Value |
|---|---|
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, Massachusetts, 02142, United States |
| Mailing address | 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, Massachusetts, 02142, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| Listed stock (Section 12(b)) | Class A common Stock, par value $0.001 per share · IMRX · The Nasdaq Global Market 10-Q filed 2026-08-05 cover |
| Shell company | No 10-Q filed 2026-08-05 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-05 cover |
| Emerging growth company | Yes 10-Q filed 2026-08-05 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-05 cover |
| Well-known seasoned issuer | No 10-K filed 2026-03-06 cover |
| Voluntary filer | No 10-K filed 2026-03-06 cover |
| First EDGAR filing | 2019-10-04 (D) |
| SEC CIK | 1790340 |
| EIN | 000000000 |
| Phone | 617-500-8080 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |